| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/17/1997 | WO1997003203A3 Generation of immune responses to prostate-specific antigen (psa) |
| 04/17/1997 | DE19538088A1 Phenanthridinderivate und ihre Herstellung Phenanthridine derivatives and their preparation |
| 04/17/1997 | CA2234666A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | CA2234484A1 Novel amine derivatives of epipodophyllotoxin 2", 3"-dideoxyglycosides, preparation method therefor and use thereof as a drug and for treating cancer |
| 04/17/1997 | CA2232231A1 Pilosulin 2 |
| 04/17/1997 | CA2231561A1 Use of a .gamma.-rar-specific agonist ligand to increase apoptosis rate |
| 04/16/1997 | EP0768380A2 Gene regulating aureobasidin sensitivity |
| 04/16/1997 | EP0768308A1 New derivatives of pyroglutaminic acid, preparation process and applications |
| 04/16/1997 | EP0768305A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 04/16/1997 | EP0768084A1 Cancerous metastasis inhibitor |
| 04/16/1997 | EP0767801A1 Endothelin antagonists ii |
| 04/16/1997 | EP0767800A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 04/16/1997 | EP0767796A1 Monocyte chemotactic protein-4 |
| 04/16/1997 | EP0767794A1 Phosphinic acid derivatives |
| 04/16/1997 | EP0767792A1 Vitronectin receptor antagonists |
| 04/16/1997 | EP0767788A1 New brefeldin a derivatives and their utility in the treatment of cancer |
| 04/16/1997 | EP0767786A1 7-ether-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
| 04/16/1997 | EP0767773A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same |
| 04/16/1997 | EP0767673A1 Methods for reduced renal uptake of antibody fragments |
| 04/16/1997 | EP0767657A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 04/16/1997 | EP0687259B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 04/16/1997 | EP0651647B1 Glutathione as chemoprotective agent |
| 04/16/1997 | EP0539479B1 Heterocyclic compounds |
| 04/16/1997 | EP0536282B1 Meducament for treating prostatic adenocarcinoma |
| 04/16/1997 | EP0527736B1 Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs |
| 04/16/1997 | EP0514515B1 Anthracycline-conjugates |
| 04/16/1997 | CN1147837A Recombinant adenoviral vector and methods of use |
| 04/16/1997 | CN1147834A Coordinate in vivo gene expression |
| 04/16/1997 | CN1147768A Compositions comprising DNA damaging agents and P53 |
| 04/16/1997 | CN1147397A Chinese patent drug for various cancers and tumors |
| 04/16/1997 | CN1034589C Method for producing antitumor antibiotic kedarcidin |
| 04/15/1997 | US5621121 Process for the preparation of taxane derivatives |
| 04/15/1997 | US5621109 Retroviral protease inhibiting compounds |
| 04/15/1997 | US5621106 Reacting with dialkyltin oxide; acylation; alkylation |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5621098 Process for preparing bis-indolyl macrocycles |
| 04/15/1997 | US5621083 Immunotoxins comprising ribosome-inactivating proteins |
| 04/15/1997 | US5621081 Polypeptide; treatment of nervous system disorders |
| 04/15/1997 | US5621077 Genetic engineering |
| 04/15/1997 | US5621002 Having a modified competitive enzyme activity inhbitor linked to a spacer-drug; enzyme cleavage at a lower concentration, i.e. low michaelis-menten constant(km) |
| 04/15/1997 | US5621001 Methods for administration of taxol |
| 04/15/1997 | US5620989 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits |
| 04/15/1997 | US5620985 Anticancer agents |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620871 Process for preparing optionally hydrogenated indigestible polysaccharides |
| 04/15/1997 | CA2104576C A method for the treatment of tumours and sarcomas |
| 04/12/1997 | CA2187576A1 Substituted biphenylsulfonamide endothelin antagonists |
| 04/10/1997 | WO1997012970A1 Antitumour vector constructs and methods |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012891A1 Polymeric platinum complex, preparation thereof, and anticancer agent comprising thereof |
| 04/10/1997 | WO1997012876A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/10/1997 | WO1997012862A1 Cbi analogs of cc-1065 and the duocarmycins |
| 04/10/1997 | WO1997012859A1 Succinimide and maleimide cytokine inhibitors |
| 04/10/1997 | WO1997012855A1 Butyrate prodrugs of lactic acid |
| 04/10/1997 | WO1997012853A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | WO1997012633A1 Dendritic cell stimulatory factor |
| 04/10/1997 | WO1997012630A1 Combination of temozolomide and alpha-ifn for the treatment of advanced cancer |
| 04/10/1997 | WO1997012625A1 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 04/10/1997 | WO1997012624A1 Novel peptides |
| 04/10/1997 | WO1997012623A1 Methods and compositions for viral enhancement of cell killing |
| 04/10/1997 | WO1997009998A3 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 04/10/1997 | WO1997005250A3 Receptor ligand vegf-c |
| 04/10/1997 | WO1996026961A3 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 04/10/1997 | DE19537334A1 New piperidine carboxylic acid and pyrrolidine carboxylic acid derivs. |
| 04/10/1997 | CA2234060A1 Methods and compositions for viral enhancement of cell killing |
| 04/10/1997 | CA2233936A1 Cbi analogs of cc-1065 and the duocarmycins |
| 04/10/1997 | CA2233888A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | CA2233606A1 Butyrate prodrugs of lactic acid |
| 04/10/1997 | CA2233544A1 Combination temozolomide and alpha-ifn for the treatment of advanced cancer |
| 04/10/1997 | CA2233272A1 Novel peptides |
| 04/10/1997 | CA2232865A1 The use of flt3 ligand to generate dendritic cells |
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | CA2187392A1 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/09/1997 | EP0767178A1 Protein which induces interferon-gamma production by immunocompetent cell |
| 04/09/1997 | EP0767170A1 Novel 4,6-diarylpyrimidine derivatives and salts thereof |
| 04/09/1997 | EP0767167A1 Trifluoromethylsulfonylphenyl or trifluoromethylsulfinylphenyl group containing 2-cyano-3-hydroxy-propenamide derivatives, process for their preparation, their use as medicaments and pharmaceutical compositions containing them |
| 04/09/1997 | EP0766696A1 Thiazolidine derivatives, their preparation and drugs containing same |
| 04/09/1997 | EP0766695A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 04/09/1997 | EP0766689A1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 04/09/1997 | EP0766688A1 Synthesis of oligonucleotides |
| 04/09/1997 | EP0766683A1 Novel substituted purinyl derivatives with immunomodulating activity |
| 04/09/1997 | EP0766679A1 Bioactive acetogenins and derivatives |
| 04/09/1997 | EP0766672A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/09/1997 | EP0766665A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766664A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766565A1 Medical use of bromelain |
| 04/09/1997 | EP0766512A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 04/09/1997 | EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 04/09/1997 | EP0638071B1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
| 04/09/1997 | CN1147260A Neurokinine (tachykinine) antagonists |
| 04/09/1997 | CN1146895A Use of bolbostemmaoside A to prepare medicine for treatment of leukemia |
| 04/08/1997 | US5618941 Benzenealkanoic acids for cardiovascular diseases |
| 04/08/1997 | US5618925 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 04/08/1997 | US5618844 Matrix metalloproteinase inhibitor |
| 04/08/1997 | US5618839 Retinoid-like compounds |
| 04/08/1997 | US5618823 Glutathione as chemoprotective agent |
| 04/08/1997 | US5618814 Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds |
| 04/08/1997 | US5618812 Benzodiazepine derivatives |
| 04/08/1997 | US5618805 19-nor-vitamin D compounds |
| 04/08/1997 | US5618536 Chimeric papillomavirus-like particles |